SavedAdd your journal

Journals / Turkish Journal of Chemistry / 2015 / Cilt: 39 - Sayı: 1

Synthesis and characterization of substituted benzimidazole Co(II), Fe(II), and Zn(II) complexes and structural characterization of dichlorobis{1-[2-(1-piperidinyl)ethyl]-1H-benzimidazole-K N3} zinc(II)

Synthesis and characterization of substituted benzimidazole Co(II), Fe(II), and Zn(II) complexes and structural characterization of dichlorobis{1-[2-(1-piperidinyl)ethyl]-1H-benzimidazole-KN3} zinc(II)

Hasan KÜÇÜKBAY
Ülkü YILMAZ
Mehmet AKKURT
Orhan BÜYÜKGÜNGÖR
Pages
108–120
Publication Date
2015-03-15
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Moreover, the crystal structure of dichlorobis{1-[2-(1-piperidinyl)ethyl]-1H-benzimidazole-KN3} zinc(II) was determined by single crystal X-ray diffraction.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The Co(II), Fe(II), and Zn(II) complexes of 1-(3-phenyl)propylbenzimidazole (PPBI), 5-nitro-1-(3-phenyl) propylbenzimidazole (PPNBI), 1-[2-(4-morpholinyl)ethyl]benzimidazole (MEBI), 1-[2-(1-piperidinyl)ethyl]benzimidazole (PEBI), and 5-nitro-1-[2-(1-piperidinyl)ethyl]benzimidazole (PENBI) were synthesized and characterized by 1H NMR, 13C NMR, and elemental analyses.
📊
Key Findings & Data:The magnitudes of the magnetic moments for paramagnetic complexes were between 4.07 and 5.11 B.M.
💡
Conclusion & Impact:Moreover, the crystal structure of dichlorobis{1-[2-(1-piperidinyl)ethyl]-1H-benzimidazole-KN3} zinc(II) was determined by single crystal X-ray diffraction.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Benzimidazole metal complexes · transition metal complexes · coordination compounds

Abstract

The Co(II), Fe(II), and Zn(II) complexes of 1-(3-phenyl)propylbenzimidazole (PPBI), 5-nitro-1-(3-phenyl) propylbenzimidazole (PPNBI), 1-[2-(4-morpholinyl)ethyl]benzimidazole (MEBI), 1-[2-(1-piperidinyl)ethyl]benzimidazole (PEBI), and 5-nitro-1-[2-(1-piperidinyl)ethyl]benzimidazole (PENBI) were synthesized and characterized by 1H NMR, 13C NMR, and elemental analyses. The magnitudes of the magnetic moments for paramagnetic complexes were between 4.07 and 5.11 B.M. Moreover, the crystal structure of dichlorobis{1-[2-(1-piperidinyl)ethyl]-1H-benzimidazole-KN3} zinc(II) was determined by single crystal X-ray diffraction.

Özet

The Co(II), Fe(II), and Zn(II) complexes of 1-(3-phenyl)propylbenzimidazole (PPBI), 5-nitro-1-(3-phenyl) propylbenzimidazole (PPNBI), 1-[2-(4-morpholinyl)ethyl]benzimidazole (MEBI), 1-[2-(1-piperidinyl)ethyl]benzimidazole (PEBI), and 5-nitro-1-[2-(1-piperidinyl)ethyl]benzimidazole (PENBI) were synthesized and characterized by 1H NMR, 13C NMR, and elemental analyses. The magnitudes of the magnetic moments for paramagnetic complexes were between 4.07 and 5.11 B.M. Moreover, the crystal structure of dichlorobis{1-[2-(1-piperidinyl)ethyl]-1H-benzimidazole-KN3} zinc(II) was determined by single crystal X-ray diffraction.

🔖

Cite This Article

KÜÇÜKBAY, H., YILMAZ, Ü., AKKURT, M., BÜYÜKGÜNGÖR, O. (2015). Synthesis and characterization of substituted benzimidazole Co(II), Fe(II), and Zn(II) complexes and structural characterization of dichlorobis{1-[2-(1-piperidinyl)ethyl]-1H-benzimidazole-K N3} zinc(II). Turkish Journal of Chemistry, Cilt: 39 - Sayı: 1, 108–120. https://ajindex.com/articles/184735

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Barros-Garcia, F. J.; Bernalte-Garcia, A.; Luna-Giles, F.; Maldonado-Rogado, M. A.; Vinuelas-Zahinos, E. Poly hedron 2005, 24, 1764–1772.
  2. Reedijk, J. Comprehensive Coordination Chemistry, Vol. 2; Pergamon: Oxford, UK, 1987, pp. 73–98.
  3. Preston, P. N. Benzimidazole and Congeneric Tricyclic Compounds, Part-2; Wiley: New York, NY, USA, 1980, pp. 531–543.
  4. Roopashree, B.; Gayathri, V.; Gopi, A.; Devaraju, K. S. J. Coord. Chem. 2012, 65, 4023–4040.
  5. Khalil, M. M. H.; Ali, S. A.; Ramadan, R. M. Spectrochimica Acta A 2001, 57, 1017–1024.
  6. Ahuja, I. S.; Prasad, I. Inorg. Nucl. Chem. Lett. 1976, 12, 777–784.
  7. Wu, H.; Yuan, J.; Bal, Y.; Pan, G.; Wang, H.; Shao, J.; Gao, J.; Wang. Y. J. Coord. Chem. 2012, 65, 4327–4341.
  8. Poyraz, M.; Sarı, M.; G¨uney, A.; Demirci, F.; Demirayak, S¸.; S¸ahin, E. J. Coord. Chem. 2008, 61, 3276–3283. C¸ etinkaya, B.; C¸ etinkaya, E.; K¨u¸c¨ukbay, H.; Durmaz, R. Arzneim.-Forsch./Drug Res. 1996, 46, 821–823. K¨u¸c¨ukbay, H.; Durmaz, B. Arzneim.-Forsch./Drug Res. 1997, 47, 667–670. K¨u¸c¨ukbay, H.; G¨unal, S.; Orhan, E.; Durmaz, R. Asian J. Chem. 2010, 22, 7376–7382.
  9. Galal, S. A.; Hegab, K. H.; Kassab, A. S.; Rodriguez, M. L.; Kerwin, S. M.; A. El-Khamry, A-M.; El-Diwani, H. I. Eur. J. Med. Chem. 2009, 44, 1500–1508. K¨u¸c¨ukbay, H.; C¸ etinkaya, B.; Guesmi, S.; Dixneuf, P. H. Organometallics 1996, 15, 2434–2439. K¨u¸c¨ukbay, H.; S¸ireci, N.; Yılmaz, ¨U.; Akkurt, M.; Yal¸cın, S¸. P.; Tahir, M. N.; Ott, H. Appl. Organometal. Chem. J. Inorg. Biochem. 2009, 103, 1204–1213. 21.G¨um¨u¸s, F.; Eren, G.; A¸cık, L.; C¸ elebi, A.; ¨Ozt¨urk, F.; Yılmaz, S¸.; Sa˘gkan, R. I.; G¨ur, S.; ¨Ozkul, A.; Elmalı, A.; et al. J. Med. Chem. 2009, 52, 1345–1357.
  10. Wu, H.-L.; Yun, R.-R.; Wang, K.-T.; Li, K.; Huang, X.-C.; Sun, T.; Wang, Y.-Y. J. Coord. Chem. 2010, 63, 243–249.
  11. Wang, J.; Jian, F. F.; Wang, X. J. Coord. Chem. 2009, 62, 2623–2630.
  12. Hu, F.; Yin, X.; Lu, J.; Mi, Y.; Zhuang, J; Luo, W. J. Coord. Chem. 2010, 63, 263–272. 36.Barros-Garcia, F. J.; Bernalte-Gracia, A.; Luna-Giles, F.; Maldonado-Rogado, M. A.; Vinuelas-Zahinos, E. Poly hedron 2005, 24, 1764–1772.
  13. Kwaskowska-Chec, E.; Kubiak, M.; Glowiak, T.; Ziolkowski, J. J. Transition Met. Chem. 1998, 23, 641–643.
  14. Wang, J.; Jian, F. F.; Wang, X. J. Coord. Chem. 2009, 62, 2623–2630.
  15. Bei, F.; Jian, F.; Yang, X.; Lu, L.; Wang, X.; Razak, I. A.; Raj, S. S. S.; Fun, H. K. Acta Cryst. C 2001, 57, 45–46. 40.Salas, J. M.; Romero, M. A.; Rahmani, A. Acta Cryst. C 1994, 50, 510–512. 41.Preston, H. S.; Kennard, C. H. L. J. Ch